KRN23 effects on phosphate and vitamin D dysregulation in children <5 years old with X-Linked Hypophosphatemia (XLH)
Erik A. Imel(Indiana University – Purdue University Indianapolis), Michael P. Whyte(Shriners Hospitals for Children - St. Louis), Gary S. Gottesman(Shriners Hospitals for Children - St. Louis), Javier San Martín(Universidad Nacional de Educación a Distancia), Meng Mao(Guiyang Medical University), Thomas Carpenter, Alison Skrinar
Cited by 2
Related Papers
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Burosumab Therapy in Children with X-Linked Hypophosphatemia
|New England Journal of Medicine|2018|479